Drug-eluting embolic microspheres: State-of-the-art and emerging clinical applications

AS Mikhail, AH Negussie… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction Drug-eluting embolic (DEE) microspheres, or drug-eluting beads (DEB),
delivered by transarterial chemoembolization (TACE) serve as a therapeutic embolic to stop …

[HTML][HTML] Emerging treatment options for gastroenteropancreatic neuroendocrine tumors

M Cives, E Pelle', J Strosberg - Journal of Clinical Medicine, 2020 - mdpi.com
Treatment options for neuroendocrine tumors (NETs) and carcinomas (NECs) are
expanding. Early-phase studies have shown preliminary evidence of the antitumor activity of …

90Y radioembolization in the treatment of neuroendocrine neoplasms: results of an international multicenter retrospective study

BM Schaarschmidt, M Wildgruber… - Journal of Nuclear …, 2022 - Soc Nuclear Med
In neuroendocrine neoplasms (NENs), the presence of distant metastases has a severe
impact on survival leading to a relevant decrease in the 5-y survival rate. Here, 90Y …

Small bowel neuroendocrine tumours–casting the net wide

SC Zammit, R Sidhu - Current Opinion in Gastroenterology, 2023 - journals.lww.com
Small bowel neuroendocrine tumours – casting the net wide : Current Opinion in
Gastroenterology Small bowel neuroendocrine tumours – casting the net wide : Current Opinion …

Neuroendocrine hepatic metastatic disease: the surgeon's perspective

SJ Concors, JE Maxwell - Abdominal Radiology, 2022 - Springer
Neuroendocrine tumors are a rare subset of tumors that are increasing in incidence over the
last 4 decades. These tumors occur along the gastrointestinal tract and bronchopulmonary …

Chemoembolization Beyond Hepatocellular Carcinoma: What Tumors Can We Treat and When?

DM DePietro, X Li… - Seminars in …, 2024 - thieme-connect.com
Liver metastases are the most common malignancy found in the liver and are 20 to 40 times
more common than primary hepatic tumors, including hepatocellular carcinoma. Patients …

[HTML][HTML] Liver metastases of neuroendocrine tumors: Conventional transarterial chemoembolization and thermal ablation

TJ Vogl, T Gruber-Rouh, NNN Naguib… - RöFo-Fortschritte auf …, 2024 - thieme-connect.com
Purpose To identify prognostic factors for patients with neuroendocrine liver metastases
(NELM) undergoing conventional transarterial chemoembolization (c-TACE), microwave …

Pancreatic neuroendocrine neoplasms: a 2022 update for radiologists

SJ Galgano, AC Morani, DR Gopireddy… - Abdominal …, 2022 - Springer
Pancreatic neuroendocrine neoplasms (PaNENs) are a unique group of pancreatic
neoplasms with a wide range of clinical presentations and behaviors. Given their …

Transarterial Therapy for Neuroendocrine Tumors: Protocol for a Systematic Review and Network Meta-analysis

A Bassir, M Konstantinidis, JT Moon, A Tran… - medRxiv, 2022 - medrxiv.org
Introduction Neuroendocrine neoplasms are a form of tumor that develops from a variety of
neuroendocrine cell types and is most commonly found in the gastrointestinal tract. As the …

[HTML][HTML] Peptide Receptor Radionuclide Therapy in Neuroendocrine Neoplasms: Aspects of tumour characteristics, receptor recycling and peptide mass

U Jahn - 2023 - diva-portal.org
Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1903. 96
pp. Uppsala: Acta Universitatis Upsaliensis. ISBN 978-91-513-1714-4. Neuroendocrine …